xCures
Bill Mahoney has a diverse work experience spanning various roles and industries. Bill currently serves as the VP of Engineering at xCures since April 2021. Previously, they worked as the Sr. Director of Data Sciences and Engineering at Spok from May 2016 to April 2021, where they excelled in delivering compelling products and leading fast-paced programs. Prior to that, they were the Sr. Product Manager - Sherlock at AudaExplore from February 2015 to May 2016, driving growth and profitability in the Driver Behavior business. Bill also worked as a Product Manager at Quantum Retail Technology from November 2013 to February 2015, Senior Technical Product Manager at Kalido from September 2007 to October 2013, Technical Product Manager at Wolters Kluwer Financial Services from October 2004 to September 2007, and Business Systems Analyst at Bankers Systems from October 2004 to April 2006. Bill started their career at US Bank, first as a Business Operations Analyst from July 2003 to October 2004, and later as a BSA/AML Investigator with responsibilities in conducting investigations, trend analysis, and maintaining international wire monitoring software.
Bill Mahoney attended the Florida Institute of Technology from 1998 to 2002, where they obtained a Bachelor of Science in Business Administration (BSBA) with a focus on Computer Science and Business Administration. There is no information provided about the specific field of study within Computer Science or Business Administration. In terms of additional certifications, Bill obtained the "Advanced NoSQL for Data Science" certification from LinkedIn in July 2019. There is no information provided regarding their enrollment or completion of any degree or program at St. Johns International.
This person is not in any offices
xCures
The convergence of genomics, precision medicine, and AI have created an unprecedented moment in the world of oncology. But the drug-centric way in which treatments are developed and the haphazard way in which knowledge about those treatments is captured and delivered to the point of care does not serve patients well. xCures is changing that, withan AI-based precision oncology platform that tightly integrates cancer research and care.The xCures platform runs a perpetual trial that captures Real World Evidence (RWE) to continuously learn from all patients, on all treatments, all the time. It coordinates treatment recommendations across all patients and institutions to match patients with the treatments that work. And it packages RWE for use by stakeholders across oncology, slashing the time and cost of drug development and saving lives.